← FDA Drug Approvals (Drugs@FDA)

ANGIOTENSIN ll ACETATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2025-06-03

Drug application

FDA Application #

ANDA216966

Application type

Abbreviated New Drug Application (Generic)

Brand name

ANGIOTENSIN ll ACETATE

Generic name

ANGIOTENSIN II

Active ingredients

ANGIOTENSIN II ACETATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

GLAND

Manufacturer

Gland Pharma Limited

First approval

2025-06-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown